Enlivex Therapeutics Ltd
Change company Symbol lookup
Select an option...
ENLV Enlivex Therapeutics Ltd
ICD Independence Contract Drilling Inc
EAC Edify Acquisition Corp
ABNAF Aben Resources Ltd
PITPY Indocement Tunggal Prakarsa Tbk PT
OPEN Opendoor Technologies Inc
CNX CNX Resources Corp
BYOC Beyond Commerce Inc
NSP Insperity Inc
SUPV Grupo Supervielle SA
Go

Health Care : Biotechnology | Small Cap Growth
Based in Israel
Company profile

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Closing Price
$11.45
Day's Change
0.51 (4.66%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.60
Day's Low
11.00
Volume
(Light)
Volume:
53,492

10-day average volume:
81,643
53,492
  • Prev Close
    10.94
  • Today's Open
    11.07
  • Day's Range
    11.00-11.60
  • Avg Vol (10-day)
    81.6K
  • Last (time)
    4:00p ET 09/21/21
  • Last (size)
    338
  • 52-Wk Range
    4.73 - 29.40
    LowHigh
  • (09/25/20 - 02/08/21)
    142.07%
  • 110.2%
  • Market Cap
    209.6M
  • Shares Outstanding
    18.3M
  • -0.93
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • --
  • (% of float 08/31/21)
    3.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.